Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study

doi:10.4251/wjgo.v14.i9.1711

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 9

This Article

(168)

(157)

(0)

(7)

(2)

(4392)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Cohort Study

World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1711-1726
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1711

Table 4 The complete response rate and univariate regression of consolidation chemotherapy in the original samples before matching, after propensity score match and inverse probability of treatment weighting in the two groups

	CR			Univariate regression
	non-CC group, n (%)	CC group, n (%)	P value	OR (95%CI)	P value
Original samples	21 (16.3)	33 (24.3)	0.107	1.648 (0.895-3.033)	0.109
PSM	17 (16.2)	29 (27.6)	0.045	1.975 (1.008-3.871)	0.047
IPTW	21 (16.3)	35 (25.9)	0.045	1.185 (1.008-3.395)	0.047

CR: Complete response; PSM: Propensity score match; IPTW: Inverse probability of treatment weighting; CC: Consolidation chemotherapy; OR: Odds rate; CI: Confident interval.

Full Size Table

Citation: Sheng XQ, Wang HZ, Li S, Zhang YZ, Geng JH, Zhu XG, Quan JZ, Li YH, Cai Y, Wang WH. Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study. World J Gastrointest Oncol 2022; 14(9): 1711-1726
URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1711.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1711

Sheng XQ, Wang HZ, Li S, Zhang YZ, Geng JH, Zhu XG, Quan JZ, Li YH, Cai Y, Wang WH. Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study. World J Gastrointest Oncol 2022; 14(9): 1711-1726 [PMID: 36187388 DOI: 10.4251/wjgo.v14.i9.1711]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.